NfL immunoreactivity was increased in patients with PD compared with controls in the parahippocampal gyrus (d = 0.89, +48%, p = 0.040), but significance did not survive multiple testing corrections (pFDR = 0.326) (Figure 2, C and D). This evidence concerns the gene NEFL and Parkinson disease.